Professor The University of Texas at Austin Austin, Texas
Join Bill Williams and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “Amorphous Solid Dispersions Require Unique Considerations for Their Formulation and Characterization”, that he is especially excited about.
T1430-03-18 Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations, Akshay Narula, MS, University of Connecticut
T1230-09-51 FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions, Gang Zhao, Ph.D., US Food and Drug Administration
M1330-07-38 Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance, Tu Van Duong, Ph.D., Purdue University
T1030-10-59 Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability, Katsutoshi Yamaguchi, MS, Astellas Pharma Inc.
M1530-07-39 Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions, Rahima Khatun, MS, Duquesne University
